Chapin Davis’s Sensus Healthcare SRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$108K Buy
36,000
+10,000
+38% +$30.9K 0.02% 250
2026
Q2
$78.5K Hold
26,000
– – 0.01% 252
2026
Q1
$103K Buy
26,000
+16,000
+160% +$71K 0.02% 256
2025
Q4
$39.8K Sell
10,000
-15,000
-60% -$55.6K 0.01% 242
2025
Q3
$78.5K Hold
25,000
– – 0.02% 242
2025
Q2
$118K Buy
25,000
+10,000
+67% +$46.8K 0.03% 224
2025
Q1
$71K Buy
15,000
+5,000
+50% +$29.1K 0.02% 217
2024
Q4
$58K Hold
10,000
– – 0.02% 227
2024
Q3
$58K Hold
10,000
– – 0.02% 229
2024
Q2
$53.3K Buy
+10,000
New +$46K 0.02% 223

Other funds holding SRTS

Chapin Davis's SRTS Position: Q3 2026 in Review

Chapin Davis increased its Sensus Healthcare (SRTS) stake by 38% in Q3 2026, buying an estimated $30.9K and bringing the position to 36,000 shares worth $108K. The position accounts for 0.02% of the portfolio, ranked #250.

Chapin Davis first reported a position in SRTS in Q2 2024 and has held it in 10 quarters since. The position peaked at $118K in Q2 2025. 8 funds tracked by Wall St. Rank hold SRTS as of Q3 2026.

  • Chapin Davis held 36,000 shares of Sensus Healthcare worth $108K as of Q3 2026.
  • Chapin Davis bought 10,000 Sensus Healthcare shares in Q3 2026, an estimated $30.9K.
  • Sensus Healthcare made up 0.02% of Chapin Davis's portfolio in Q3 2026, its #250 holding.
  • Chapin Davis first reported a position in Sensus Healthcare in Q2 2024 and has held it in 10 quarters since.
  • Chapin Davis's Sensus Healthcare position peaked at $118K in Q2 2025.
  • 8 funds tracked by Wall St. Rank held Sensus Healthcare as of Q3 2026.

Based on Chapin Davis's 13F filing for Q3 2026, filed 9 Oct 2026.